Corporate Compliance Policies
It is Amgen policy to comply with all regulations and laws worldwide relating to adverse event or experience, other safety finding, and product complaint reporting (collectively known as “Reportable Events”). All covered persons are responsible for reporting reportable events to the appropriate unit within one business day of learning of the reportable event. Prompt and accurate reporting of reportable events is critical to protecting the health and safety of patients who use Amgen’s products around the world.
Amgen seeks to compete lawfully and ethically in the marketplace. We will not tolerate acts or attempts to improperly influence government personnel or private individuals to secure improper advantage for Amgen's business interests. Any Amgen employee who violates the U.S. Foreign Corrupt Practices Act, any foreign law equivalents, or our Code of Conduct or associated policies will be subject to discipline up to and including termination of employment.
Amgen's Anti-Bribery and Anti-Corruption (ABAC) Program embodies the Company's commitment to preventing unlawful bribery and corruption in all countries where it operates. Upon hire, and annually thereafter, all employees are trained on our Anti-Bribery and Anti-Corruption Policy as part of our Code of Conduct training, with select groups receiving additional tailored, function-centric training. Employees must certify completion of training. Additionally, we conduct an annual ABAC risk assessment to identify and monitor ABAC risks. We use the results to inform our mitigation actions and auditing plan.
Amgen engages an external party to conduct an independent assessment of our ABAC Program every three years. These assessments help ensure our ABAC Program meets the expectations and guidelines of enforcement agencies and provide opportunities for ongoing validation and enhancement.
Amgen does not tolerate any business transaction or activity that violates the antitrust and competition laws or regulations of any country or region in which we conduct business.
It is Amgen’s policy to promote a culture of accountability for ethical business conduct, professional behavior, personal integrity, and adherence to acceptable business practices. Amgen works to provide an effective process for Amgen staff or their representatives to express concerns and report potential violations regarding Amgen business conduct, and does not tolerate retaliation, intimidation or harassment against anyone who in good faith reports a concern, participates in any investigation or other proceeding related to a concern, or engages in any whistleblower or other reporting activities. To the extent permitted by local regulations and applicable law, Amgen takes measures to maintain the confidentiality and protect the identity of staff members who report potential misconduct or unethical behavior.
Amgen staff are responsible for avoiding situations in which a reasonable person may question whether an activity, practice or relationship creates or could be perceived to create a conflict with Amgen’s interests.
Amgen is committed to conducting operations in an environmentally responsible way, complying with all environmental, health, safety and sustainability laws and regulations.
Amgen is committed to complying with applicable laws, regulations and industry standards regarding the use of proprietary information as well as the maintenance of recorded information that evidences our operations.
Amgen requires all staff, consultants, contract workers and temporary workers globally, including their family members, to comply with the U.S. insider trading laws and regulations.
Amgen expects staff members to comply with all laws and regulations that govern the promotion and provision of scientific information. Promotional information and scientific exchange must be truthful and not misleading. Scientific exchange must be non-promotional in nature and intent.
Amgen respects personal privacy and is committed to protecting, securing and appropriately processing the personal information that has been entrusted to us. We have appropriate safeguards to protect personal information and address reported privacy incidents in a prompt manner.
Amgen seeks to comply with all laws and regulations related to the export and import of goods, services, technology, software and knowledge. We have implemented controls to avoid transactions with an individual or company with whom trade is legally prohibited.
Amgen requires that the use of external and internal social media comply with all applicable laws and adhere to the highest standards of professional ethics and responsibility. Staff must ensure that their use of social media for Amgen-related purposes is appropriate and authorized.